Recent Updates — ALMU

Aeluma, Inc. reported fourth quarter and full fiscal year 2026 financial results alongside strategic business updates. For Q4 ended June 30, 2026, revenue was $0.6 million with a net loss of $4.0 million ($0.22 per share). Full-year revenue totaled $4.5 million against a net loss of $9.2 million ($0.52 per share). The company raised $20.1 million in net proceeds from an at-the-market offering, bringing cash and equivalents to $56.0 million. Aeluma signed a letter of intent for up to $30 million under the CHIPS R&D Office program for AI photonics development and executed six new contracts totaling $5.3 million with customers including NASA and the U.S. Navy. The firm also announced partnerships with Tower Semiconductor and Sumitomo Chemical Advanced Technologies to expand wafer capacity. Aeluma, Inc. is a semiconductor company specializing in high-performance photonic and electronic technologies for AI, defense, aerospace, and quantum applications.

Aeluma, Inc. announced on July 29, 2026, that it signed a Letter of Intent with the U.S. Department of Commerce for up to $30 million in proposed funding under the CHIPS and Science Act. The award supports research and development of Aeluma’s scalable, non-indium phosphide semiconductor manufacturing platform for photonics, aiming to address supply chain constraints for AI datacom applications. The funding is subject to due diligence, government approvals, and execution of definitive documents, with a portion funded upfront and the remainder tied to milestones. Additionally, executing final award documents would require Aeluma to issue equity securities to the U.S. Department of Commerce valued at the award amount. Aeluma operates in the semiconductor industry, specializing in high-performance photonic and electronic technologies for AI, defense, and mobile applications.